Jensen Investment Management Inc. grew its stake in Genpact Limited (NYSE:G - Free Report) by 2.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 195,485 shares of the business services provider's stock after purchasing an additional 5,500 shares during the quarter. Jensen Investment Management Inc. owned about 0.11% of Genpact worth $8,396,000 at the end of the most recent quarter.
Several other large investors have also bought and sold shares of the company. SRH Advisors LLC purchased a new stake in shares of Genpact in the 4th quarter worth about $26,000. Manchester Capital Management LLC bought a new position in Genpact in the 4th quarter worth about $38,000. Smartleaf Asset Management LLC grew its position in Genpact by 416.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock valued at $41,000 after purchasing an additional 783 shares during the last quarter. UMB Bank n.a. increased its stake in Genpact by 55.7% during the 4th quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock valued at $52,000 after purchasing an additional 433 shares in the last quarter. Finally, J.Safra Asset Management Corp increased its stake in Genpact by 38.8% during the 4th quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider's stock valued at $69,000 after purchasing an additional 453 shares in the last quarter. 96.03% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several research firms recently commented on G. Mizuho increased their price objective on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research report on Monday, February 10th. Needham & Company LLC increased their price target on Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a report on Friday, February 7th. Jefferies Financial Group upgraded Genpact from a "hold" rating to a "buy" rating and upped their price objective for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Finally, TD Cowen raised Genpact from a "hold" rating to a "buy" rating and raised their target price for the stock from $45.00 to $60.00 in a research report on Friday, February 7th. Six investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $48.44.
Get Our Latest Stock Report on G
Genpact Stock Performance
Shares of NYSE G traded up $0.17 during trading on Tuesday, hitting $50.54. The company had a trading volume of 613,901 shares, compared to its average volume of 1,304,599. The stock has a 50 day simple moving average of $49.71 and a 200 day simple moving average of $44.38. The firm has a market capitalization of $8.88 billion, a P/E ratio of 17.84, a price-to-earnings-growth ratio of 1.84 and a beta of 1.16. Genpact Limited has a 12 month low of $30.23 and a 12 month high of $56.76. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16.
Genpact (NYSE:G - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. As a group, analysts anticipate that Genpact Limited will post 3.21 earnings per share for the current year.
Genpact Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th will be given a dividend of $0.17 per share. This is an increase from Genpact's previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.35%. The ex-dividend date is Tuesday, March 11th. Genpact's dividend payout ratio is currently 23.94%.
Insider Activity at Genpact
In related news, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the sale, the senior vice president now directly owns 151,182 shares of the company's stock, valued at $6,475,125.06. This represents a 7.35 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Balkrishan Kalra sold 13,600 shares of the business's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the transaction, the chief executive officer now owns 310,246 shares of the company's stock, valued at $15,167,926.94. This trade represents a 4.20 % decrease in their position. The disclosure for this sale can be found here. 2.80% of the stock is currently owned by insiders.
Genpact Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Further Reading

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.